GGrantIndex
Sort

64,565 grants matching drug discovery

Unlocking the cidal activity of echinocandins against Aspergillus fumigatus

$471,816
Jarrod R. Fortwendel · University Of Tennessee Health Sci Ctr · R01 · FY2021 · AI

T Cell Activation in Lymph Nodes

$471,776
Ulrich H Von Andrian · Harvard Medical School · R01 · FY2015 · AI

T Cell Activation in Lymph Nodes

$471,776
Ulrich H Von Andrian · Harvard Medical School · R01 · FY2014 · AI

Janus Liposomes: Formation, Self-Assembly and Controlled Motion

$471,772
Wei Zhan · Auburn University · · FY2018 · MPS

A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore.

$471,756
Paraskevi Giannakakou · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA

Development of New Therapeutics for Amyotrophic Lateral Sclerosis

$471,756
Robert H Brown · Univ Of Massachusetts Med Sch Worcester · U01 · FY2008 · NS

Product Development Core

$471,688
Julian P Whitelegge · University Of California Los Angeles · U19 · FY2019 · AI

Bruker ELEXSYS-II E500 X-band CW EPR spectrometer system

$471,670
Candice S Klug · Medical College Of Wisconsin · S10 · FY2024 · OD

Improved NMR Technology for Natural Products and Metabolomics.

$471,609
Arthur S Edison · University Of Florida · R01 · FY2010 · EB

Novel Non-Peptide Antagonists of the GnRH Receptor

$471,580
Neurocrine Biosciences, Inc. · R44 · FY2002 · HD

Novel Non-Peptide Antagonists of the GnRH Receptor

$471,580
Neurocrine Biosciences, Inc. · R44 · FY2001 · HD

Project 3: CRISPR Genome Editing to Understand and Correct STAT3 GOF Immune Dysregulation

$471,566
Alexander Marson · University Of California, San Francisco · P01 · FY2023 · AI

Identification of novel y-globin corepressors and advanced inhibitor development

$471,562
James Douglas Engel · University Of Michigan At Ann Arbor · P01 · FY2022 · HL

DNA Sequencing

$471,556
Beatrice H Hahn · University Of Alabama At Birmingham · P30 · FY2010 · AI

Integrative analysis and modeling of human immune responses and pathologies

$471,538
John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

Research Career Development Core (RCDC)

$471,521
Michael J Lichtenstein · University Of Texas Hlth Science Center · P30 · FY2016 · AG

New Leads for Triple Negative Breast Cancer from Diverse Natural Sources

$471,519
Susan L Mooberry · University Of Texas Hlth Science Center · U01 · FY2014 · CA

Use of Novel Cox-2 Inhibitors in Neurological Disorders

$471,502
Onconova Therapeutics, Inc. · R44 · FY2005 · NS

Project 1: Laboratory: Pharmacotherapies for Cannabis Use Disorders

$471,478
Margaret Haney · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · U54 · FY2015 · DA

Resolving ensemble averaged conformations by multi-temperature x-ray crystallography

$471,468
James Solomon Fraser · University Of California, San Francisco · R01 · FY2019 · GM

Multidisciplinary Educational Approach to Reducing Cancer Disparities

$471,463
J. Silvio Gutkind · University Of California, San Diego · R25 · FY2019 · CA

Dendrimer-conjugated nSMase2 inhibitor as a novel therapeutic approach for Alzheimer's Disease

$471,402
Rana Rais · Johns Hopkins University · R01 · FY2024 · AG

Dendrimer-conjugated nSMase2 inhibitor as a novel therapeutic approach for Alzheimer's Disease

$471,402
Rana Rais · Johns Hopkins University · R01 · FY2023 · AG

Interdepartmental Training in Pharmacological Sciences

$471,299
Lori L Isom · University Of Michigan At Ann Arbor · T32 · FY2018 · GM

Three-dimensional Structures Of Biological Macromolecules

$471,280
Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL